Fidelity evaluation of the dialogue around respiratory illness treatment (DART) program communication training.
Acute respiratory illness
Antibiotic prescribing
Clinician-parent communication
Pediatrics
Journal
Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
29
09
2021
revised:
04
03
2022
accepted:
10
03
2022
pubmed:
29
3
2022
medline:
18
6
2022
entrez:
28
3
2022
Statut:
ppublish
Résumé
To evaluate receipt fidelity of communication training content included in a multifaceted intervention known to reduce antibiotic over-prescribing for pediatric acute respiratory tract infections (ARTIs), by examining the degree to which clinicians implemented the intended communication behavior changes. Parents were surveyed regarding clinician communication behaviors immediately after attending 1026 visits by children 6 months to < 11 years old diagnosed with ARTIs by 53 clinicians in 18 pediatric practices. Communication outcomes analyzed were whether clinicians: (A) provided both a combined (negative + positive) treatment recommendation and a contingency plan (full implementation); (B) provided either a combined treatment recommendation or a contingency plan (partial implementation); or (C) provided neither (no implementation). We used mixed effects multinomial logistic regression to determine whether these 3 communication outcomes changed between baseline and the time periods following each of 3 training modules. After completing the communication training, the adjusted probability of clinicians fully implementing the intended communication behavior changes increased by an absolute 8.1% compared to baseline (95% Confidence Interval [CI]: 2.4%, 13.8%, p = .005). Our findings support the receipt fidelity of the intervention's communication training content. Clinicians can be trained to implement communication behaviors that may aid in reducing antibiotic over-prescribing for ARTIs.
Identifiants
pubmed: 35341612
pii: S0738-3991(22)00104-5
doi: 10.1016/j.pec.2022.03.011
pmc: PMC9203931
mid: NIHMS1790133
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Banques de données
ClinicalTrials.gov
['NCT02943551']
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Pagination
2611-2616Subventions
Organisme : NICHD NIH HHS
ID : R01 HD084547
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Références
Patient Educ Couns. 2006 Apr;61(1):117-25
pubmed: 16406461
Pediatrics. 2020 Sep;146(3):
pubmed: 32747473
Health Technol Assess. 2019 Mar;23(11):1-70
pubmed: 30900550
Arch Pediatr Adolesc Med. 2001 Jul;155(7):800-6
pubmed: 11434847
Ann Fam Med. 2019 Mar;17(2):125-132
pubmed: 30858255
Soc Sci Med. 2005 Mar;60(5):949-64
pubmed: 15589666
Patient Educ Couns. 2002 Aug;47(4):301-9
pubmed: 12135821
Pediatrics. 2016 Sep;138(3):
pubmed: 27485697
BMJ. 2012 Feb 02;344:d8173
pubmed: 22302780
Lancet. 2013 Oct 5;382(9899):1175-82
pubmed: 23915885
Health Commun. 2005;18(1):41-74
pubmed: 15918790
Ann Fam Med. 2015 May-Jun;13(3):221-7
pubmed: 25964399
JAMA. 2014 Dec 17;312(23):2569-70
pubmed: 25317759
BMJ. 2021 Apr 28;373:n808
pubmed: 33910882
Syst Rev. 2020 May 8;9(1):106
pubmed: 32384919
PLoS Med. 2019 Feb 5;16(2):e1002733
pubmed: 30721234
Health Psychol. 2004 Sep;23(5):443-51
pubmed: 15367063